Narcyz Ghinea

Narcyz Ghinea is a leading researcher investigating how institutional drivers influence patient access to medications and other health services. His work focuses on overcoming the legal, policy, and political barriers that impede access to health technologies and generate systemic inequities. Areas of focus include therapeutic goods regulation, health technology assessment, medical negligence law, professional duties, medical epistemology, and commercial determinants of health.

In 2021 Narcyz was granted the prestigious Macquarie University Research Fellowship to pursue his work. Prior he had been appointed to various Research Fellow positions at the Centre for Values, Ethics and the Law in Medicine, Sydney Health Ethics, and Sydney Law School, all based at the University of Sydney. He has published in leading journals across multiple disciplines including the Lancet, BMJ, American Journal of Bioethics, the Journal of Medical Ethics, the Hastings Centre Report, Health Policy, and Sociology of Health and Illness. He is a member of the editorial boards for PLOS One and the Journal of Bioethical Inquiry, and is a board member of the Prescription Justice Institute (a not-for-profit based in New York).

Prevously, Narcyz served in several health management and policy related roles at the NSW Ministry of Health, Clinical Excellence Comission, the South Eastern Sydney Local Health District, the South Western Sydney Local Health District, and Sydney Local Health District. He was also long-standing Secretariat for the Medication Safety Expert Advisory Committee, a peak committee of NSW Health. This experience gives Narcyz deep practical insights into health service delivery which informs his work.

In recognition of his expertise, Narcyz is regularly consulted by various local and international organisations including the Therapeutic Goods Administration, NSW Health, Medicines Sans Frontieres, Local Health Districts, and Research Australia among other organisations, and regularly contributes his expertise to public policy consultations. He was also invited as a Visiting Fellow to the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Vienna, Austria.

Narcyz helped to develop and coordinate the Masters unit on Medicines Policy, Economics and Ethics at the University of Sydney. He continues to guest lecture on topics relating to ethical challenges in pharmaceutical policy and drug development at the University of Sydney.